International Aloe Science Council names Jane Wilson as interim executive director

FDA warns Health Breakthrough International for alleged cGMP compliance issues with aloe products

Editor's Note: FDA sent Health Breakthrough International a warning letter for several alleged cGMP violations for several aloe products, including not conducting at least one appropriate test to verify identity,  not establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests, and  failing to identify on the label the part of the plant used. The company was also warned for not having written procedures for calibrating the scale or  reviewing and approving components, labels, packaging, or finished product for distribution.
1234